Introduction Antisense oligonucleotides (ASOs), first described by Zamecnik and Stephenson in 1978, were used to inhibit the translation of viral proteins1. Despite the temporary disappearance […]
Category: Targeting
Targeting oncofetal fibronectin and neuropilin-1 in solid tumors with PL2 peptide
Introduction Tumor blood vessels have emerged as critical targets for therapeutic intervention. Therapeutic strategies include suppressing the growth or perturbing functions of the neovessels that […]